Small Molecule Microarray News Today

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Kronos Bio Presents Preclinical Data for Oral CDK9 Inhibitor KB-0742 Demonstrating Sustained ... Kronos Bio, Inc.April 10, 2021 GMT MYC genomic amplification found to be a key driver of sensitivity to CDK9 inhibition Pan-cancer anti-tumor activity, including in tumors exposed to prior lines of therapy, seen with intermittent dosing of KB-0742 Initial safety, pharmacokinetic and pharmacodynamic data fr...